Skip to main content
Exenatide Research

Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes

Diabetes Care·September 1, 2025

Diabetes research group

Summary

Changes in β-cell function and insulin sensitivity during treatment with dapagliflozin alone or in combination with exenatide.

Study Details
Study Design

Mechanistic clinical study

Indication

Type 2 diabetes

Intervention

Dapagliflozin alone or with exenatide

Species

Human

External Links
Metrics
Citations
0
Evidence QualityN/A
Related PeptideExenatide6 papers